High NANOG expression correlates with worse patients’ survival in esophageal adenocarcinoma

BACKGROUND: Patients diagnosed with esophageal cancer demonstrate a low overall survival even despite the established multimodal therapy as the current standard of care. Therefore, further biomarkers for patients with high-risk and additional therapy options are needed. NANOG is a transcription fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Knipper, Karl, Damanakis, Alexander I., Lyu, Su Ir, Simon, Adrian Georg, Wahler, Isabell, Bruns, Christiane J., Schröder, Wolfgang, Schmidt, Thomas, Quaas, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351130/
https://www.ncbi.nlm.nih.gov/pubmed/37461005
http://dx.doi.org/10.1186/s12885-023-11146-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10351130/
https://www.ncbi.nlm.nih.gov/pubmed/37461005
http://dx.doi.org/10.1186/s12885-023-11146-0

Ejemplares similares